CVE-2020-4897

Description

IBM Emptoris Contract Management and IBM Emptoris Spend Analysis 10.1.0, 10.1.1, and 10.1.3 could allow a remote attacker to obtain sensitive information when a detailed technical error message is returned in the browser. This information could be used in further attacks against the system. IBM X-Force ID: 190988.

Category

5.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.26%
Vendor Advisory ibmcloud.com Vendor Advisory ibm.com Vendor Advisory ibm.com
Affected: IBM Emptoris Contract Management
Affected: IBM Emptoris Spend Analysis
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/6398276 patch vendor advisory
https://www.ibm.com/support/pages/node/6398280 patch vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/190988 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2020-4897?
CVE-2020-4897 has been scored as a medium severity vulnerability.
How to fix CVE-2020-4897?
To fix CVE-2020-4897, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-4897 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-4897 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-4897?
CVE-2020-4897 affects IBM Emptoris Contract Management, IBM Emptoris Spend Analysis.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.